




- 51 - 
BIOKEMISTRI 14: 51-56 (January 2003) 




Effect of Tetracycline on Late-stage African trypanosomiasis in Rats 
 
Titilayo O. JOHNSON and Justine T. EKANEM* 
 
Department of Biochemistry, University of Ilorin, PMB 1515, Ilorin, Nigeria 
 
Received 4 November 2002           
MS/No BKM/2002/030, © 2003 Nigerian Society for Experimental Biology. All rights reserved. 
-------------------------------------------------------------------------------------------------------------------------------------------- 
Abstract 
The effect of tetracycline on late stage African trypanosomiasis was examined in 
an in vivo experiment using rats infected with Trypanosoma brucei brucei.  
Infected rats were treated on the 5th day of infection with 10mg/kg and 20mg/kg 
rat weight of tetracycline and tetracycline hydrochloride.  Tetracycline at 10mg/kg 
extended the life-span of infected rats from 6 days to 11 days, but with 20mg/kg 
the rats died on day 6. Tetracycline–HCl at 10 and 20mg/kg extended the life-
span to 9 and 12 days respectively.  The trypanocidal effect of tetracycline on 
late stage trypanosomiasis is probably due to its ability to penetrate the blood 
brain barrier and its probable role in inhibiting ribonucleotide reductase through 
iron chelation. We suggest that tetracycline-HCl and low concentrations of 
tetracycline can be used in the clinical management of African Trypanosomiasis.  
 
Key words: African trypanosomiasis, Tetracycline, Late Stage 
-------------------------------------------------------------------------------------------------------------------------------------------- 
















Human African trypanosomiasis is a fatal 
disease which affects some 36 developing 
African countries south of the Sahara.  It exist 
in the rural areas and about 300,000 new cases 
are reported annually (WHO, 1998).  Upon 
infection through the bite of a tsetse fly the 
parasite proliferate rapidly by binary fission.  
Lymph and blood are invaded and the 
organism progressively disseminate to the 
bone marrow and tissue fluids, and in the 
second stage (late-stage) it penetrate the 
central nervous system and cerebrospinal fluid 
(Masake et al, 1997). 
 
Therapy of human African trypanosomiasis in 
the early stage relies on pentamidine, suramin, 
or diminazene aceturate (Atouguia and Costa, 
1999), none of which could cross the blood 
brain barrier in sufficient quantity to prevent 
relapses of late-stage cases of the disease 
(Keiser et al, 2001).  Melarsoprol was 
introduced in 1949 and is used in the 
treatment of late-stage trypanosomiasis but 
severe adverse events frequently occur.  
DFMO which is the most recent of the drugs 
is not effective against T. b. rhodesiense and is 
very expensive (Seebeck et al, 1999).  
Furthermore there is a constant threat that 
production of the currently used drugs will be 
interrupted because it is not profitable.  New 
cost efficient and easy to use drugs are 
therefore urgently needed (Keiser et al, 2001). 
 
Tetracycline, an antimicrobial drug with iron-
chelating property (Grenier et al, 2000) have 
been found in a previous experiment to be 
effective against the early stage of the 
infection and the trypanocidal action was 
suggested to be as a result of iron-chelation 
(Ekanem et al, 2002) which could inhibit 
ribonucleotide –reductase, the iron-requiring 
cell cycle-dependent enzyme that plays a 
central role in cell division and proliferation.  
In this study we have examined the effect of 
tetracycline and tetracycline-HCl which is 
the commercially available form of the drug 
on the parasitaemia and life-span of rats 
infected with T. b. brucei. 
 
MATERIALS AND METHODS 
 
Lafia strain of T. b. brucei was collected 
from the veterinary and Livestock Studies 
Department, Nigerian Institute for 
Trypanosomiasis Research (VSL-NITR), 
Vom near Jos in Nigeria.  Wister rats 
weighing approximately 200g were obtained 
from the Animal House, Department of 
Biochemistry, University of Ilorin.  
Tetracycline and Tetracycline hydrochloride 
were products of Sigma Chemical Company, 
Poole, England.  The parasite was passaged 
intraperitoneally into rats and parasitaemia 
was observed on a daily basis by counting 
parasites in thin blood smears under light 
microscope.  Drugs were administered 
intraperitoneally twice daily.  10mg/kg and 
20mg/kg tetracycline and tetracycline–HCl 
were administered to infected rats from the 
5th day of infection until the rats died.  
Control rats were infected but not treated 
with any drug. 
 
RESULTS AND DISCUSSION 
 
10mg/kg tetracycline extended the life span 
of infected rats from 6 days for the control 
to 11 days, but the rats died on day 6 when 
20mg/kg tetracycline was administered (fig 
1).  This could be as a result of the high 
volume of water used for dissolving it, since 
tetracycline is only sparingly soluble in 
water (Sande and Mandell, 1980) 10 and 
20mg/kg tetracycline-HCl reduced the 
parasitaemia and extended the lifespan of 
infected rats to 9 and 12 days respectively 
(fig 2). The fact that low concentration of 
tetracycline effectively extents the life span 
of infected rat (fig 1) is probably because 






than tetracycline–HCl as previously 
determined (Ekanem et al, 2002). 
 
The effect of Tetracycline on late stage 
trypanosomiasis in this experiment may be 
attributed, firstly, to its antimicrobial 
activity.   
 
Fig. 1: Parasite count in T. brucei infected rats treated with 
tetracycline twice daily as the infection progressed until 
death. Treatment of rats started with 10mg/kg and 20mg/kg 


































Fig. 2: Parasite count in T. brucei - infected rats treated with 
Tetracycline - HCl twice as the infection progressed until 
death. Treatment of rats started with 10mg/kg and 20mg/kg 

































It has the ability to suppress the growth of 
bacteria, as it does to periodontopathogenic 
gram-negative anaerobic bacteria, in the 
treatment of periodontitis, a disease affecting 
the tooth-supporting tissues (Rifkin et al, 
1993).  Secondly, the iron-chelating activity 
of tetracycline have been suggested to 
contribute to its antimicrobial activity 
(Grenier, et al, 2000), and it has been shown 
in a previous experiment that the 
trypanocidal action of tetracycline is related 
to this property (Ekanem et al, 2002).  
Another factor is that the distribution of 
tetracycline in most body fluids and tissues is 
excellent (Sande and Mandell, 1980).  
Depending on route and duration of 
treatment, tetracycline penetrates the 
cerebrospinal fluid (Sande and Mandell, 
1980).  The intravenous injection of the drug 
results in the gradual appearance of the 
drug in the spinal fluid over a period of 6 
hours.  Oral therapy yields very low spinal 
fluid concentrations.  The rickettsial 
disorders which are diseases involving the 
central nervous system are treated 
effectively with tetracycline-derivatives 
(Bleck, 1999). We have earlier suggested 
the possible use of tetracycline for early 
stage of African trypanosomiasis (Ekanem 
et al, 2002).  From the results of this 
experiment we also suggest that 
tetracycline at low concentration and 
tetracycline HCl can extend the life span of 
infected rats and may therefore be 
considered as a possible drug for the 
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